Europe clears Picato for actinic keratoses

The European Commission has granted marketing authorization to LEO Pharma for Picato gel, for the treatment of actinic keratosis (AK).

Related Videos
Related Content

Alternative Care Options for Inflammatory Diseases

June 7th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Combination Trichloroacetic, Lactic Acid Effective in Reducing Signs of Facial Photoaging

June 7th 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Understanding How Data Analytics Help Improve Health Outcomes With Stefan Weiss, MD

June 6th 2023

Tildrakizumab Improved Sleep, Quality of Life in Patients With Plaque Psoriasis

June 6th 2023

Alternative Care Options for Inflammatory Diseases

June 7th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Combination Trichloroacetic, Lactic Acid Effective in Reducing Signs of Facial Photoaging

June 7th 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Understanding How Data Analytics Help Improve Health Outcomes With Stefan Weiss, MD

June 6th 2023

Tildrakizumab Improved Sleep, Quality of Life in Patients With Plaque Psoriasis

June 6th 2023

Alternative Care Options for Inflammatory Diseases

June 7th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Combination Trichloroacetic, Lactic Acid Effective in Reducing Signs of Facial Photoaging

June 7th 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Understanding How Data Analytics Help Improve Health Outcomes With Stefan Weiss, MD

June 6th 2023

Tildrakizumab Improved Sleep, Quality of Life in Patients With Plaque Psoriasis

June 6th 2023
© 2023 MJH Life Sciences

All rights reserved.